Belvedere Trading LLC Voyager Therapeutics, Inc. Transaction History

Belvedere Trading LLC

  • $82.2 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022
SELL
$4.82 - $10.09 $47,756 - $99,971
-9,908 Reduced 27.26%
26,432 $182,000
Q1 2022

Apr 20, 2022
BUY
$2.75 - $9.44 $4,628 - $15,887
1,683 Added 4.86%
36,340 $347,000
Q4 2021

Jan 25, 2022
SELL
$2.47 - $5.55 $69,243 - $155,588
-28,034 Reduced 44.72%
34,657 $98,000
Q3 2021

Oct 19, 2021
BUY
$2.63 - $4.12 $164,877 - $258,286
62,691 New
62,691 $285,000

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.8M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $218M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email